Association between NAD (P) H: Quinone Oxidoreductase 1 C609T Gene Polymorphism and Risk Factors in Cases of Cervical Cancer in Indian Women

NAD(P)H:醌氧化还原酶1 C609T基因多态性与印度女性宫颈癌风险因素的关联

阅读:3

Abstract

INTRODUCTION: HPV infection is causative agent for cervical cancer, majority of HPV infections are low-grade, self-limited, and revert spontaneously in some HPV infection fails to clear this hints towards presence of certain genetic factors which predispose them to increase risk of pre-cancer and cancer. We aimed to investigate the factors which have bearing on rising cancer cases in India and to elucidate the genetic susceptibility distribution of NAD (P) H: quinone oxidoreductase 1 C609T gene polymorphism. MATERIALS AND METHODS: Study recruited 142 women with biopsy-proven cervical cancer (the case group) and 142 women with normal cytology (the control group). DNA extracted from blood via QIAamp DNA mini kit. The DNA of each participant was amplified and the genotype and allelic frequency were compared. RESULTS: In our study, maximum women in the case group had stage II (69.7%) squamous cell carcinoma (97.2%). 75.4% of the cases had moderately differentiated carcinoma and had no treatment before (43.7%). Among cases, the prevalence of genotype CC, CT and TT was 42.3%, 19.7% and 38.0%, respectively compared to 54.9%, 13.4% and 31.7%, in controls. The odds of having CC (odds ratio [OR] =0.64; 95% confidence interval [CI] =0.38-1.08), CC or CT in contrast to TT (OR = 0.756; 95% CI = 0.46-1.23), CC in contrast to TT/CT (OR = 0.694; 95% CI = 0.44-1.10) was lesser in cases compared to the controls, while Odds of allele T as compared to C were significantly elevated in cases as compared to that in the controls (OR = 1.48; 95% CI = 1.06-2.06). The proportion of TT genotype was elevated in advanced stages as compared to early stages. CONCLUSION: We found the odds of allele T as compared to C were markedly elevated in cases as compared to controls.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。